Effects of switching from a reduced dose imiglucerase to velaglucerase in type 1 Gaucher disease: clinical and biochemical outcomes
Disclosures and Contributions
Files in this Data Supplement:
Adobe PDF - 2011_059071-Disclosures.pdf
Adobe PDF - 2011_059071-Contributions.pdf